UBS Group’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1K | Hold |
|
|||||
|
2025
Q1 | $2.45K | Sell |
|
|||||
|
2024
Q4 | $1.98K | Sell |
|
|||||
|
2024
Q3 | $4.66K | Buy |
|
|||||
|
2024
Q2 | $3.06K | Sell |
|
|||||
|
2024
Q1 | $2.94K | Sell |
|
|||||
|
2023
Q4 | $5.4K | Buy |
|
|||||
|
2023
Q3 | $3.9K | Buy |
|
|||||
|
2023
Q2 | $6.62K | Buy |
|
|||||
|
2023
Q1 | $3.51K | Sell |
|
|||||
|
2022
Q4 | $6.54K | Buy |
|
|||||
|
2022
Q3 | $1K | Hold |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $12K | Buy |
|
|||||
|
2021
Q4 | $18K | Buy |
|